Mankind Pharma Share Price
2337.30-31.50 (-1.33%)
-8.67% past 1 Year
Mankind Pharma is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with
Corporate filings & documents
Announcements
Please find attached intimation regarding allotment of 49 112 equity shares pursuant to ESOP Plan
2 days agoPlease find attached intimation regarding allotment of 49 112 equity shares pursuant to ESOP Plan
2 days agoPlease find attached final update on sale of stake of Broadway Hospitality Services Private Limited a wholly owned subsidiary company.
3 days agoPlease find attached final update on sale of stake of Broadway Hospitality Services Private Limited a wholly owned subsidiary company.
3 days agoPlease find attached intimation regarding completion of term of Independent Director
4 days agoPlease find attached intimation regarding completion of term of Independent Director
4 days agoPlease find attached outcome of the Board Meeting held today according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limited a wholly owned material subsidiary into the Company by way of voluntary liquidation.
1 week agoPlease find attached outcome of the Board Meeting held today according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limited a wholly owned material subsidiary into the Company by way of voluntary liquidation.
1 week agoPlease find attached outcome of Board Meeting held today according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limtied a wholly owned material subsidiary into the Company by way of voluntary liquidation.
1 week agoPlease find attached outcome of Board Meeting held today according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limtied a wholly owned material subsidiary into the Company by way of voluntary liquidation.
1 week agoPlease find attached intimation regarding ESG Rating
1 week agoPlease find attached intimation regarding ESG Rating
1 week agoPlease find attached press release dated August 20 2026.
2 weeks agoPlease find attached press release dated August 20 2026.
2 weeks agoPlease find attached Newspaper Advertisement of Notice of Postal Ballot
2 weeks agoPlease find attached Newspaper Advertisement of Notice of Postal Ballot
2 weeks agoPlease find attched postal ballot notice
2 weeks agoPlease find attched postal ballot notice
2 weeks agoCompletion of realignment of Security Cover in respect of Non-Convertible Debentures.
2 weeks agoPlease find attached intimation regarding incorporation of a wholly owned subsidiary company in Netherlands
3 weeks agoPlease find attached intimation regarding incorporation of a wholly owned subsidiary company in Netherlands
3 weeks agoPlease find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
3 weeks agoPlease find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
3 weeks agoPlease find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
3 weeks agoPlease find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
3 weeks agoPlease find attached outcome of board meeting
3 weeks agoPlease find attached outcome of board meeting
3 weeks agoPlease find attached intimation regarding participation in Investor Conferences
3 weeks agoPlease find attached intimation regarding participation in Investor Conferences
3 weeks agoPlease find attached Voting Results and Scrutinizers Report of 35th AGM
4 weeks agoPlease find attached Voting Results and Scrutinizers Report of 35th AGM
4 weeks agoPlease find attached proceedings of the 35th AGM of the Company
1 month agoPlease find attached proceedings of the 35th AGM of the Company
1 month agoPlease find attached transcript of the Investor Conference call for Q1FY27 held on July 30 2026
1 month agoPlease find attached transcript of the Investor Conference call for Q1FY27 held on July 30 2026
1 month agoPlease find attached Newspaper Advertisement - Unaudited Financial Results of the company for the quarter ended on June 30 2026
1 month agoPlease find attached Newspaper Advertisement - Unaudited Financial Results of the company for the quarter ended on June 30 2026
1 month agoInvestor Conference call for Q1FY27 - Audio Recording
1 month agoInvestor Conference call for Q1FY27 - Audio Recording
1 month agoPlease find attached certificate under Regulation 54 of the SEBI (LODR) Regulations 2015
1 month agoPlease find attached certificate under Regulation 54 of the SEBI (LODR) Regulations 2015
1 month agoPlease find attached press release on financial results of the Company for Q1FY27
1 month agoPlease find attached press release on financial results of the Company for Q1FY27
1 month agoPlease find attached investor presentation for Q1FY27
1 month agoPlease find attached investor presentation for Q1FY27
1 month agoBoard of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bharat Serums & Vaccines Limited a WOS.
1 month agoBoard of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bharat Serums & Vaccines Limited a WOS.
1 month agoPlease find attached un-audited financial results of the Company for the quarter ended on June 30 2026
1 month agoPlease find attached un-audited financial results of the Company for the quarter ended on June 30 2026
1 month agoOutcome of Board Meeting
1 month agoAnnual reports
Concalls & investor presentations
Jul 2026
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
Jan 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Nov 2024
Jul 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Jan 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Oct 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Corporate Actions
Date
Type
Details
2025-08-08
Dividend
1.0
Company details
Registered office
208 Okhla Industrial Estate Phase - 111 New Delhi Delhi PIN: 110020 Tel No: 011-46846700 / 47476600 Fax No: 011-46541383 Email: [email protected] Internet: www.mankindpharma.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Hitesh Kumar Jain, Company Secretary & Compliance Officer
Ramesh Juneja, Chairman
Rajeev Juneja, Vice Chairman & Managing Director
Sheetal Arora, Whole Time Director & Chief Executive Officer
Satish Kumar Sharma, Whole Time Director
T P Ostwal, Non Executive Independent Director
Vijaya Sampath, Non Executive Independent Woman Director
Bharat Anand, Non Executive Independent Director
Vivek Kalra, Non Executive Independent Director
Details
BSE 543904
NSE MANKIND
ISIN INE634S01028